Skip to main content

Table 2 Changes in the mean systolic blood pressure and QTc interval following each infusion of combretastatin A-4 phosphate (SE = Standard error)

From: Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate

Ā 

1st infusion

2nd infusion

3rd infusion

4th infusion

mmHg (SE)

QTc in Ī¼m (SE)

mmHg (SE)

QTc in Ī¼m (SE)

mmHg (SE)

QTc in Ī¼m (SE)

mmHg (SE)

QTc in Ī¼m (SE)

Prior to Infusion

145 (4.8)

411 (3.51)

131 (3.38)

406 (3.25)

136 (4.78)

412 (3.58)

132 (7.11)

415 (6.14)

Hour 1

164 (7.9)

419 (4.41)

165 (5)

405 (4.75)

163 (9.48)

416 (3.44)

154 (4.84)

417 (4.82)

Hour 2

149 (6.66)

430 (10.12)

148 (5.53)

427 (8.09)

148 (5.32)

428 (6.62)

139 (6.56)

425 (8.75)

Hour 3

143 (6.31)

424 (7.23)

141 (2.95)

422 (4.78)

139 (5.33)

428 (6.01)

136 (7.8)

424 (7.47)

Hour 4

144 (7.6)

426 (4.93)

137 (4.5)

426 (4.78)

131 (5.75)

424 (5.09)

128 (6.63)

423 (7.35)

Hour 5

148 (9.7)

423 (7.55)

137 (5.08)

429 (12.83)

142 (3.62)

423 (6.61)

138 (5.72)

421 (7.65)